NCT05272852View on ClinicalTrials.gov

The FARAPULSE PersAFOne III Trial for the Treatment of Persistent Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 3, 2022

Primary Completion Date

February 9, 2024

Study Completion Date

February 9, 2024

Conditions
Persistent Atrial Fibrillation
Interventions
DEVICE

FARAPULSE™ Pulsed Field Ablation System Plus

Ablation using FARAPULSE™ Pulsed Field Ablation System Plus

Trial Locations (2)

637 00

Neuron Medical, Brno

Unknown

Nemocnice Na Homolce, Prague

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY